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Knockdown of Zebrafish Fancd2
Causes Developmental Abnormalities
via p53-Dependent Apoptosis
2003). Following exposure to DNA-damaging agents or
during the DNA synthesis (S) phase of the cell cycle, six
of the FA proteins (A, C, E, F, G, and L) assemble into
a multisubunit nuclear complex that activates the
monoubiquitination of the downstream FANCD2 (D2)
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protein at lysine 561. Monoubiquitination of the D2 pro-Department of Pediatric Oncology
tein targets its translocation to BRCA1-, FANCD1/Dana-Farber Cancer Institute and
BRCA2-, and RAD51-containing nuclear DNA repair fociHarvard Medical School
(Garcia-Higuera et al., 2001; Taniguchi et al., 2002a).Boston, Massachusetts 02115
Biallelic mutation of an upstream FA gene disrupts the
monoubiquitination of FANCD2, resulting in the loss of
FANCD2 foci and hypersensitivity to mitomycin CSummary
(MMC). However, despite major advances in the under-
standing of the biochemistry of FA proteins, little isMechanisms underlying the multiple developmental
known about the mechanisms through which mutationsdefects observed in Fanconi anemia (FA) patients are
affecting essential components of this pathway lead tonot well defined. We have identified the zebrafish ho-
the diverse congenital abnormalities found in FA pa-molog of human FANCD2, which encodes a nuclear
tients. To address this problem, we conducted studieseffector protein that is monoubiquitinated in response
exploiting the advantages of the zebrafish system.to DNA damage, targeting it to nuclear foci where
The zebrafish is becoming an important vertebrateit preserves chromosomal integrity. Fancd2-deficient
model for the study of human diseases (Grunwald andzebrafish embryos develop defects similar to those
Eisen, 2002; Zon, 1999). This model offers several uniquefound in children with FA, including shortened body
advantages, such as large numbers of embryos perlength, microcephaly, and microophthalmia, which are
clutch, rapid and external embryonic development, anddue to extensive cellular apoptosis. Developmental
optical clarity, which allows the direct visualization ofdefects and increased apoptosis in Fancd2-deficient
organogenesis. Marked similarities between humanszebrafish were corrected by injection of human FANCD2
and zebrafish at the level of genes and genomic syntenyor zebrafish bcl2 mRNA, or by knockdown of p53, indi-
have been well documented, along with the conserva-cating that in the absence of Fancd2, developing tis-
tion of developmental and signal transduction pathwayssues spontaneously undergo p53-dependent apopto-
(Bennett et al., 2001; Brownlie et al., 1998; Langenau etsis. Thus, Fancd2 is essential during embryogenesis
al., 2003; Liu et al., 2002). These attributes make theto prevent inappropriate apoptosis in neural cells and
zebrafish a useful vertebrate model for the dissectionother tissues undergoing high levels of proliferative
of molecular pathways of human disorders, particularlyexpansion, implicating this mechanism in the congeni-
those affecting early embryologic development, suchtal abnormalities observed in human infants with FA.
as FA.
In this study, we analyze the function of the zebrafishIntroduction
homolog of the human FANCD2 gene, because it is
the critical downstream target in the FA pathway. We
Fanconi anemia (FA) is a rare autosomal recessive disor-
demonstrate that in its absence, marked developmental
der, characterized by multiple developmental abnormal-
defects arise during zebrafish embryogenesis, mirroring
ities, bone marrow failure, and cancer susceptibility the congenital abnormalities frequently observed among
(D’Andrea and Grompe, 1997, 2003). The congenital de- FA patients. We show that the defects in Fancd2-defi-
fects most frequently observed in FA patients include cient embryos are the result of inappropriate and selec-
microophthalmia, microcephaly, deformities of the thumbs tive activation of p53-mediated apoptotic pathways in
or forearms, and developmental delay (Grompe and highly proliferative cells, such as those in the developing
D’Andrea, 2001; Tischkowitz and Hodgson, 2003). The eye and central nervous system. To our knowledge, this
large range of tissues and organs affected in FA patients work provides the first genetic link between FA and
indicate that the FA pathway plays an important func- increased p53-dependent programmed cell death dur-
tion during early embryogenesis; however, the under- ing development.
lying molecular mechanisms are not yet understood
(D’Andrea and Grompe, 1997). Results
Currently, at least nine FA complementation groups
have been defined, and eight of the FA genes have been fancd2 Is a Structural and Functional Homolog
cloned (A, C, D1/BRCA2, D2, E, F, G, and L; de Winter of Human FANCD2
et al., 1998, 2000a, 2000b; Howlett et al., 2002; Lo Ten The full-length zebrafish fancd2 cDNA (4,831 base pairs)
Foe et al., 1996; Meetei et al., 2003; Strathdee et al., contains a predicted open reading frame encoding a
1992; Timmers et al., 2001). The eight FA proteins inter- 1,445 amino acid protein, which shares 50% amino acid
act in a common pathway (D’Andrea and Grompe, 1997, identity and 65% similarity with its human counterpart
(GenBank accession number AY301038). The posttrans-
lational modifications of two amino acids, K561 and S222,*Correspondence: thomas_look@dfci.harvard.edu
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homologs of each of these six human genes: fc14d11,
fa07b12, fk52b01, fi32f05, fancd2, and fc51c07. Each of
these homologs was located within the same region of
zebrafish chromosome 6 (Figure 1B, right). The observa-
tion that genomic synteny is conserved across this
group of genes indicates that fancd2 is the bona fide
zebrafish homolog of human FANCD2.
Previous studies have demonstrated that normal hu-
man fibroblasts and lymphoblasts express two isoforms
of the FANCD2 protein, an unmodified form, FANCD2-S,
(D2-S, 155 kDa) and a longer, monoubiquitinated form,
FANCD2-L (D2-L, 162 kDa). FANCD2-L is activated in
response to DNA-damaging agents such as MMC or
ultraviolet light (UV), and exhibits slower electrophoretic
mobility due to the monoubiquitination of lysine 561
(K561) of the FANCD2-S protein (Garcia-Higuera et al.,
2001). Another distinct posttranslational modification of
FANCD2 is phosphorylation of serine 222 by ATM follow-
ing exposure to -irradiation (IR), which is required for
the IR-induced S phase checkpoint (Taniguchi et al.,
2002b).
Because of the conservation of K561 and S222 in
the Fancd2 protein (Figure 1A), we next investigated
whether Fancd2 could be posttranslationally modified
in response to DNA-damaging agents. Western analysis
showed that a rabbit polyclonal E35 antiserum against
human FANCD2 could also specifically recognize the
Fancd2 protein in a zebrafish fibroblast cell line, AB9
(Figure 1C). When AB9 cells were treated with MMC
(Figure 1C, upper panels) or UV (Figure 1C, lower pan-
els), both Fancd2-L and -S proteins were expressed and
the Fancd2-L protein demonstrated a time-dependentFigure 1. Structural and Functional Conservation of the Fancd2
Protein increase, similar to the activated pattern observed for
(A) Conservation of the two critical amino acid residues S222 and human FANCD2-L following exposure to MMC or UV
K561 (denoted by arrowheads) in human and zebrafish (zfish) (Figure 1C, compare lanes 1–6 with 7–12). The Fancd2-L
Fancd2 proteins. Bars and double dots denote identical and similar and FANCD2-L were activated with similar kinetics follow-
amino acids, respectively. ing UV treatment. However, the time course was delayed
(B) The fancd2 gene resides within a region of zebrafish chromo-
for Fancd2-L (20 hr) relative to human FANCD2-L (6 hr)some 6 that is syntenic with the human FANCD2 locus. Left: six
after MMC treatment (Figure 1C, upper panels, lanes 10genes including FANCD2 are located within a 1.2 Mb genomic region
and 2, respectively), probably due to the fact that AB9on human chromosome 3p25.3, according to the latest version of the
human genome draft (http://genome.ucsc.edu/). Right: six zebrafish cells were cultured at lower temperature (28.5C). Both
homologs of these genes are listed according to their map positions forms of the human and zebrafish proteins also exhibited
on chromosome 6, and respective syntenic relationships are indi- a subtle mobility shift following IR treatment (data not
cated (http://zfin.org/). shown), which in human cells has been shown to result
(C) Exponentially growing human HeLa cells and zebrafish AB9 fibro-
from S222 phosphorylation by ATM in human (Taniguchiblasts were untreated or exposed to mitomycin C (MMC; 40 ng/ml)
et al., 2002b).from 0 to 72 hr as indicated (upper panels). Lower panels show
these cell types treated with ultraviolet light (UV; 60 J/m2) from 0
to 24 hr as indicated. Anti-human FANCD2 polyclonal antibody (E35) Knockdown of Fancd2 Induces Hypersensitivity
was used for Western analysis. D2, FANCD2; d2, Fancd2; L, long to DNA-Crosslinking Agents
form; S, short form. Human FA cells exhibit a pronounced increase in spon-
taneous chromosomal breakage following the addition
of the DNA-crosslinking agents diepoxybutane (DEB) or
which are critical to the regulation of FANCD2 function MMC, and this finding forms the basis of the diagnosis
(Garcia-Higuera et al., 2001; Taniguchi et al., 2002b), are of FA in human patients (D’Andrea and Grompe, 1997).
appropriately conserved in fancd2 (Figure 1A, arrow- To assay chromosomal instability in zebrafish cells, we
heads). blocked Fancd2 synthesis by using an antisense mor-
In human, there are six genes in the vicinity of the pholino, a technique proven to specifically block transla-
FANCD2 locus: FLJ22405 (Hs.27556); ARPC4 (Hs.323342); tion of target proteins in vivo in the zebrafish embryo
LOC152257; LOC55831 (Hs.283714); FANCD2 (Hs.15607); (Heasman, 2002; Nasevicius and Ekker, 2000) and in
and SLC6A11 (Hs.123639). Together, these genes define vitro in mammalian cell lines (Morcos, 2001). Zebrafish
a 1.2 Mb genomic region on chromosome 3p25.3 (Figure fibroblast AB9 cells were transfected with a fluorescein-
1B, left). By using the “reciprocal best hit” method (Bar- labeled fancd2 morpholino or with a control morpholino.
bazuk et al., 2000; Liu et al., 2002), we identified zebrafish In these experiments, “control” morpholino oligonucleo-
tide sequences contain mismatches in four base pairs,expressed sequence tags (ESTs) that are the respective
Fancd2 and p53-Dependent Apoptosis
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Figure 2. Knockdown of the Fancd2 Protein in Zebrafish AB9 Fibroblasts Results in Hypersensitivity to the Interstrand DNA-Crosslinking
Agent Diepoxybutane
Exponentially growing fibroblasts were transfected with fluorescein-labeled control or fancd2 morpholino oligonucleotides.
(A) Cells transfected with fluorescein-labeled fancd2-morpholino oligonucleotides (green) were counterstained with DAPI (blue). Note that the
morpholino is localized to the cytoplasm. The scale bar represents 10 m.
(B) Immunoblotting using an anti-human FANCD2 polyclonal antibody (E35) of the zebrafish AB9 cells transfected with morpholino oligonucleo-
tides. The middle panel shows the nonspecific bands in the same blot, serving as loading controls. The blot was scanned to determine the
intensity of signals shown in the lower panel. d2, Fancd2; L, long form; S, short form.
(C) Chromosomal breakage analysis of the fancd2 morpholino transfected cells after treatment with diepoxybutane (DEB; 100 ng/ml) for 2
days. Radial formation and breakage of the metaphase chromosomes are indicated (arrows). The scale bar represents 500 nm.
(D) Percentages of metaphase chromosomes exhibiting radial forms in control and fancd2 morpholino transfected fibroblasts following
exposure to varying concentrations of DEB. Fifty to one hundred metaphases were scored for radial formations.
which prevents their efficient binding to the target fancd2 mRNA Is Maternally Provided
and Ubiquitously ExpressedmRNA. Twenty-four hours after transfection, green fluo-
rescence was detected in the cytoplasm of AB9 cells, throughout Embryogenesis
To examine the spatial and temporal expression ofdemonstrating that greater than 80% of the cells were
transfected (Figure 2A). Western blot analysis of the cell fancd2 during embryogenesis, mRNA whole-mount in
situ hybridization assays were performed using digoxi-lysates showed a reduction in Fancd2 protein levels in
the fancd2 morpholino-transfected cells (Figure 2B, lane genin-labeled sense and antisense RNA probes (Figure
3A). No staining was detected using a sense control3), when compared to untransfected and control mor-
pholino-transfected cells (Figure 2B, lanes 1 and 2). RNA probe at any developmental time point tested (data
not shown). fancd2 expression was observed betweenCytogenetic analysis of metaphase chromosomes
prepared from AB9 cells transfected with the fancd2 0.75 hr postfertilization (hpf) and 3.7 hpf (blastula stages),
and then was not detected between 6 hpf (gastrulamorpholino and treated with DEB demonstrated a dose-
dependent increase in radial forms with gaps and breaks stages) and 12 hpf (6-somite stage). Following 12 hpf,
faint fancd2 mRNA expression was again observed and(Figure 2C). In Fancd2 “knockdown” cells, the percent-
ages of radial forms increased to 40% with exposure to by 18 hpf (18-somite stage), fancd2 expression in-
creased dramatically. By 24–30 hpf, fancd2 mRNA was100 ng/ml of DEB, compared to 14% for control morpho-
lino-transfected cells and 9% for untransfected wild- expressed strongly in the eye and brain, with weaker
expression levels detected in the trunk and tail.type cells treated with the same concentration of DEB
(Figure 2D). These results indicate the conservation of Northern analysis was performed to quantitate the
observed levels of embryonic fancd2 mRNA expression.one of Fancd2’s functional roles in the zebrafish, namely
to maintain chromosomal stability in cells that have been As shown by in situ hybridization assays, the 4.8 kb
fancd2 was not detectable at 6 and 9 hpf (Figure 3B,exposed to DNA-crosslinking agents.
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Figure 3. Expression of Zebrafish fancd2 dur-
ing Embryogenesis and Knockdown of Fancd2
Protein by Morpholino Injection In Vivo
(A) Spatio-temporal expression of fancd2
mRNA. Whole-mount mRNA in situ hybridiza-
tion was performed at the indicated stages.
All embryos are lateral views with the animal
pole up (0.75–6 hpf) and head to the left, dor-
sal upward (12–30 hpf). Note that expression
levels of fancd2 mRNA are lost at 6 hpf, faintly
detected at 12 hpf, and higher again by 30
hpf. The eye is indicated (e) as a point of ref-
erence.
(B) Quantitation of fancd2 mRNA by Northern
analysis. Thirty micrograms of total RNA was
extracted from wild-type embryos at the indi-
cated time points and loaded onto each lane.
Twelve micrograms of total RNA from adult
zebrafish kidney was loaded as a positive
control for the 4.8 kb fancd2 mRNA transcript.
The corresponding 28S RNA loading controls
are shown in the lower panel.
(C) Western analysis of embryo lysates at
the indicated embryonic stages using anti-
human FANCD2 polyclonal antibody E35 (up-
per panel), as well as an anti-mouse -actin
monoclonal antibody as a loading control
(lower panel). Protein lysates from 15 em-
bryos were loaded in each lane.
(D) Low-level expression of the Fancd2-long
form (d2-L) protein during embryogenesis.
Lysates of deyolked embryos at 18 and 28 hpf
were analyzed with the same human FANCD2
polyclonal antibody used in (C).
(E) Knockdown of Fancd2 protein by morpho-
lino injection in vivo. Western analysis of em-
bryos injected with fancd2 or control morpho-
linos at the indicated doses. The proteins
extracted from ten 28 hpf embryos were
loaded onto each lane. WT, uninjected; C,
control morpholino.
lanes 4 and 5), and was only faintly detectable at 12 hpf zebrafish embryos provides an efficient and specific
means to block the translation of specific proteins during(Figure 3B, lane 6). During zebrafish embryogenesis,
zygotic gene transcription starts right after the midblas- early development (Gamse et al., 2002; Nasevicius and
Ekker, 2000).tula transition, which occurs at 3.7 hpf (Kane and Kim-
mel, 1993). Therefore, the expression of fancd2 detected To determine the embryonic phenotype after “knock-
down” of the Fancd2 protein, we first determined thebefore this stage indicates the expression of maternally
derived mRNA. Interestingly, the onset of zygotic tran- minimum amount of the antisense morpholino that could
effectively block Fancd2 protein synthesis in vivo. Asscription of fancd2 was delayed until 12 hpf. Thus, there
was a period between 6 and 12 hpf in which fancd2 shown in Figure 3E, a dramatic decrease in the levels
of Fancd2 protein was observed 28 hr after the injectionmRNA could not be detected. However, Western blot
analysis found that Fancd2 proteins were maintained at of 1 ng of the fancd2-specific morpholino into one-cell
stage embryos (lane 4), and complete loss of detectableconstant levels between 6 and 12 hpf (Figure 3C, lanes
3 and 4), throughout the time period when fancd2 mRNA Fancd2 protein was observed after injection of 8 ng/
embryo of the same morpholino (lane7). By contrast,is undetectable (Figure 3B). Because zygotic transcrip-
tion of fancd2 began at 12 hpf, the relatively stable the injection of 8 ng of the four-base pair mismatch
control morpholino had no effect on the levels of Fancd2Fancd2 protein levels observed prior to this stage were
likely to be maternally provided or derived from the (lane 2). Thus, we injected morpholinos at the dosage
of 8 ng/embryo to investigate the embryonic phenotypetranslation of maternal mRNAs (Figure 3C). In addition,
both Fancd2-S and -L forms could be detected in em- resulting from a knockdown of the Fancd2 protein.
bryo lysates at 18 and 28 hpf (Figure 3D, lanes 2 and
3), suggesting that the activated from of Fancd2 can Developmental Defects Observed in Fancd2-
occur spontaneously during early zebrafish development. Deficient Zebrafish Embryos Are Caused
by Massive Cellular Apoptosis and Are Rescued
by Human FANCD2 mRNAMorpholino-Induced “Knockdown” of Fancd2
Protein Levels In Vivo In order to control for variability in the microinjection
technique, the morpholinos were tagged with fluores-Previous studies have demonstrated that the injection
of morpholino-based antisense oligonucleotides into cein so that their concentration and distribution within
Fancd2 and p53-Dependent Apoptosis
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Figure 4. Morphologic and Apoptotic Phenotypes of Fancd2-Deficient Embryos
In each panel, control morpholino-injected embryos are shown in the top row and Fancd2-deficient embryos in the bottom row, at the
same magnification.
(A) Fourteen hpf embryos (left, bright field; middle, FITC; right, TUNEL cells, red dots).
(B) Twenty-eight hpf embryos (left, bright field; right, TUNEL cells, red dots). Arrow denotes the midbrain-hindbrain boundary.
(C) Fifty-four hpf embryos (left, FITC; right, magnified bright field view of head). Note that the size of the otic placode (o) was not affected.
(D) One hundred twenty hpf embryos (bright field). Lateral view of all embryos with head upward, dorsal right in (A), and head left, dorsal
upward in (B)–(D). e, eyes; s, somites; o, otic placode.
each injected embryo could be monitored and com- a few scattered apoptotic cells were seen distributed
throughout the embryos. This random pattern was main-pared (Figure 4A, middle panels and Figure 4C, left pan-
els). Green fluorescence in the injected embryos shows tained through 18 hpf, and by 24 hpf the total numbers
of apoptotic cells were reduced overall, an observationcomparable levels of fancd2 and control morpholinos.
The fancd2 morpholino-injected embryos appeared nor- consistent with previous studies (Cole and Ross, 2001).
In Fancd2-deficient embryos, the opaque region con-mal through the 90% epiboly stage (9 hpf). The earliest
abnormal phenotype could be observed at 14 hpf, when taining dead cells became more prominent by 28 hpf,
and the sizes of the head and eye appeared relativelyan opaque region (by phase microscopy) containing
dead cells appeared in the developing somites near the small when compared with those of control embryos
(Figure 4B, left panels). While high numbers of TUNEL-yolk sac of Fancd2-deficient embryos, which was clearly
distinguishable from phase-bright somites in control positive cells were distributed throughout the whole
body of Fancd2-deficient embryos, they were concen-embryos (Figure 4A, left panels). Although the size of
the head and eye appeared relatively normal at this time, trated mostly in the head (Figure 4B, right panels) and tail
(data not shown), corresponding with opaque regionsthe boundaries of the somites (S) were less distinct and
abnormally shaped in Fancd2-deficient embryos. To ex- of the embryo. This analysis indicates the increased
activation of cellular apoptotic pathways in regions ofamine whether the increased apoptotic activity was
correlated with this apparent cell death, we analyzed morphological abnormalities. With progressing devel-
opmental age (2–5 days), the morphological conse-the developing embryos for TUNEL-positive cells. In
Fancd2-deficient embryos, dramatic increases in apo- quences of this increased cell death consistently re-
sulted in a marked overall reduction in body length (19%ptotic cells distributed throughout the head and trunk
were observed at 14 hpf (Figure 4A, right panels); how- reduction) as well as smaller heads (41% reduction) and
eyes (31% reduction) (Figures 4C and 4D). However,ever, increased apoptosis was not observed in these
embryos at 9 hpf or younger (data not shown). In control some tissues, such as the otic placode (o), remained
relatively unaffected (Figure 4C, right panel), suggestingembryos, apoptosis was not observed until 14 hpf, when
Developmental Cell
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embryos (designated as fancd2mo), when compared toTable 1. Phenotype Scores in Injected Embryos
wild-type embryos and control morpholino-injected em-
Small Head 
bryos (Figure 5A, lane 3 vs. lanes 1 and 2). In addition,Embryos Small Eyes 
downstream targets of the p53 pathway, mdm2 andInjection Injected Short Size
p21WAF1/CIP1, were also correspondingly upregulated in
(A) fancd2 Morpholino
the fancd2mo embryo (lane 3). Interestingly, cyclin D1
Uninjected 200 2% (4/200) was downregulated and cyclin E was slightly decreased
fancd2-Cmo (8 ng) 273 8.3% (21/273) in fancd2mo embryos, suggesting a cell cycle delay at the
fancd2mo (8 ng) 386 100% (386/386) G1-S transition resulting from Fancd2 loss. By contrast,
(B) Human FANCD2 mRNA Rescue bax, a downstream target of p53 involved in the p53-
mediated apoptotic pathway, was not transcriptionallyfancd2mo  GFP-huFANCD2 (300 pg) 82 44% (36/82)
regulated in the fancd2mo embryo. These results are rep-fancd2mo  GFP (300 pg) 26 100% (56/56)
resentative of similar analyses on additional single em-
(C) p53 Morpholino Rescue
bryos (wild-type, n  4; fancd2-Cmo, n  4; fancd2mo,
fancd2mo  p53mo (4 ng) 98 0% (0/98) n  8; data not shown) and suggest that in the absence
fancd2mo  p53-Cmo (4 ng) 86 100% (86/86) of Fancd2, the p53-driven apoptotic pathway is acti-
fancd2-Cmo  p53mo (4 ng) 78 0% (0/78)
vated, leading to the observed increases in TUNEL-posi-fancd2-Cmo  p53-Cmo (4 ng) 78 0% (0/78)
tive cells and the resultant abnormal embryonic phe-
(D) bcl2 mRNA Rescue notype.
fancd2mo  bcl2-GFP (90 pg) 98 0% (0/98)
fancd2mo  GFP (90 pg) 56 100% (56/56) Developmental Defects Are Rescued
in p53-Deficient Embryosfancd2mo : fancd2 morpholino injection.
p53mo : p53 morpholino injection. Langheinrich and coworkers showed that the injection
Cmo: four-base pair mismatch control morpholino injection. of 4 ng/embryo of a p53-specific morpholino specifically
huFANCD2 : human FANCD2. blocks the translation of the zebrafish p53 protein and
inhibits p53-induced apoptosis (Langheinrich et al., 2002).
Hence, different combinations of the fancd2-specific
morpholino (fancd2mo) and p53-specific morpholinothat there is tissue specificity associated with the acti-
(p53mo), as well as their respective control morpholinosvated apoptosis caused by the loss of Fancd2. All
(Cmo), were coinjected into one-cell stage embryos. FromFancd2-deficient embryos reproducibly exhibited this
14 hpf to 3 dpf, the fancd2mo-injected embryos exhibitedabnormal developmental phenotype, compared with
the same developmental defects with or without the8.3% of control morpholino-injected embryos and less
injection of the control p53-Cmo (Figure 5B, right panel;than 2% of uninjected embryos (Table 1A).
Figure 4B), However, the coinjection of p53mo with theTo test the specificity of the effects of the fancd2
fancd2mo was able to rescue the developmental defects,morpholino on development, we coinjected the green
restoring the normal body length and the normal size offluorescence protein (GFP)-tagged human FANCD2
head and eyes (Figure 5B, middle panel). To assay and(GFP-huFANCD2; 300 pg) with the fancd2 morpholino (8
quantitate levels of apoptosis associated with these re-ng) into one-cell stage embryos. GFP-positive embryos
spective morpholino injections, embryos were pro-were identified at 10 hpf (Supplemental Figure S1A, in-
cessed by TUNEL assay, stained with Hoechst 33258set and middle panel, at http://www.developmentalcell.
to visualize cell nuclei, and analyzed by confocal micros-com/cgi/content/full/5/6/903/DC1), and by 24 hpf, we
copy to count and compare relative numbers of TUNEL-observed that both the developmental defects and the
positive and -negative cells (Figure 5B, lower panels).increased apoptosis were partially corrected by overex-
While the coinjection of p53-Cmo with fancd2mo resultedpression of GFP-huFANCD2 in 56% of Fancd2-deficient
in 30% of cells undergoing apoptosis, the coinjectionembryos (Table 1B; Supplemental Figures S1A and S1B,
of p53mo with fancd2mo resulted in a dramatic decreasemiddle). In contrast, overexpression of control GFP
in cellular apoptosis back to wild-type levels (Figure 5C).mRNA was not able to rescue these developmental de-
Thus, the developmental defects and increased cellularfects (Table 1B; Supplemental Figures S1A and S1B,
apoptosis induced by the loss of Fancd2 were rescuedright). By 72 hpf, these rescued phenotypes became
in a p53-deficient background (Table 1C).more obvious (Supplemental Figure S1C). These results
Consistent with these data, the upregulation ofindicate that injection of the fancd2 morpholino caused
p21WAF1/CIP1 and mdm2 and the downregulation of cyclinspecific developmental defects by inducing apoptosis,
D1 observed in fancd2mo-injected embryos were re-and that the increased apoptosis was due to the resul-
versed when p53mo was coinjected with fancd2mo intotant deficiency of Fancd2, because it could be rescued
embryos (Figure 5A, lane 4). Thus, the loss of p53 sup-by expression of the human FANCD2 protein.
presses the Fancd2-deficient embryonic phenotype of
increased cellular apoptosis and its associated develop-Genes Involved in the p53 Pathway
mental defects.Are Upregulated in Fancd2-Deficient Embryos
Semiquantitative reverse transcriptase PCR (RT-PCR)
was performed on RNA extracted from individual mor- Developmental Defects Are Rescued
by Overexpression of Zebrafish bcl2pholino-injected embryos to determine the expression
levels of zebrafish p53, p21WAF1/CIP1, mdm2, cyclin D1, Bcl2 inhibits apoptosis mediated by the p53 pathway
(Cory and Adams, 2002). We have identified the zebra-cyclin E, and bax, relative to-actin as a control. Upregu-
lation of p53 mRNA was obvious in Fancd2-deficient fish bcl2 homolog, based on the conservation of the
Fancd2 and p53-Dependent Apoptosis
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Figure 5. Altered Gene Expression and Morphological Rescue of Fancd2-Deficient Embryos in a p53-Deficient Background
(A) Genes involved in the p53 pathway were analyzed by single-embryo RT-PCR in fancd2 (fd2), p53, and respective control morpholino-
injected embryos (designated as fancd2mo, p53mo, and Cmo, respectively). Similar results (data not shown) were obtained from RT-PCR analysis
of a number of assayed individual embryos: WT (n  4), fancd2-Cmo (n  4), fancd2mo (n  8), p53mo (n  4), and p53-Cmo (n  4).
(B) Top panels: morphology of Fancd2-deficient 28 hpf embryos coinjected with either a p53 morpholino (p53mo) or a control morpholino (p53-
Cmo). Arrows in (B) indicate the midbrain-hindbrain boundary, which is restored in p53mo-injected, but not in p53-Cmo-injected, Fancd2-deficient
embryos. Bottom panels: representative examples of TUNEL-positive cells in these respective embryos were visualized by confocal microscopy.
TUNEL cells are seen in red and Hoechst 33258-stained nuclei are in blue. The scale bar represents 20 m (bottom panel).
(C) Percentages of TUNEL cells counted from three independent embryos (400–500 cells were counted per embryo) for WT, fancd2mo 
p53mo, and fancd2mo  p53-Cmo, as shown in (B).
sequences among human, mouse, and zebrafish, and human FANCD2 gene. The encoded zebrafish Fancd2
have also shown that GFP-tagged Bcl2 is able to inhibit protein shares 50% identity and 65% similarity with hu-
developmentally regulated apoptosis in normal zebra- man FANCD2, and two important amino acids, S222
fish embryos (D.M.L., unpublished data). When bcl2- and K561, are conserved (Garcia-Higuera et al., 2001;
GFP mRNA (90 pg) was coinjected with 8 ng of the Taniguchi et al., 2002b). Biochemically, the Fancd2-L
fancd2 morpholino into one-cell stage embryos, the ab- protein is activated following exposure to MMC and UV,
normal Fancd2mo apoptotic phenotype was rescued with similar kinetics to those observed for the human
(Figures 6A and 6C). Embryos injected with fancd2 mor- FANCD2 protein (Figure 1C; Garcia-Higuera et al., 2001).
pholino and a control GFP-only mRNA failed to rescue Furthermore, knockdown of Fancd2 in zebrafish cells
the abnormal phenotype or apoptosis (Figures 6B and resulted in increased chromosomal breakage after treat-
6D). Western analysis using a GFP-specific antibody ment with the crosslinking agent diepoxybutane (Figure
showed that the level of zebrafish Bcl2-GFP fusion pro- 2), which is analogous to effects produced by this agent
tein (53.5 kDa) was relative high at 14 hpf, but decreased in human cells (D’Andrea and Grompe, 1997, 2003).
by 28 hpf and was undetectable by 72 hpf (Figure 6E, Taken together, these data indicate that fancd2 is the
lanes 1–3), unlike the relatively stable expression of the bona fide structural and functional homolog of human
GFP protein alone (27.5 kDa; Figure 6E, lanes 4 and 5). FANCD2.
Thus, the expression of Bcl2 from microinjected mRNA
during embryogenesis blocks the effects of p53-medi-
ated apoptosis and the resultant developmental defects Fancd2 Loss of Function in Zebrafish:
that are otherwise observed in Fancd2-deficient em- A Vertebrate Model of Fanconi Anemia
bryos (Table 1D). Greater than 60% of Fanconi anemia (FA) patients have
developmental defects, such as growth retardation,
short stature, microcephaly, and microophthalmia atDiscussion
birth, in addition to a highly elevated risk of bone marrow
failure in the first decade of life (Tischkowitz and Hodg-We have identified the zebrafish fancd2 gene and shown
that it is the structural and functional homolog of the son, 2003). Furthermore, FA patients have a greater than
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Figure 6. Developmental Defects Are Corrected by Transient Expression of Zebrafish bcl2 in Fancd2-Deficient Embryos
(A and B) Morphology of Fancd2-deficient 28 hpf embryos coinjected with 90 pg of either (A) bcl2-GFP mRNA or (B) control GFP mRNA. GFP
fluorescence was diffuse throughout the cells of each injected embryo (insets). The arrow in (B) indicates the opaque region containing dead
cells in the head of these embryos.
(C) Very few TUNEL-positive cells (arrow) were detected in bcl2-GFP-injected, Fancd2-deficient embryos.
(D) TUNEL-positive cells (arrow) were detected in the control GFP-injected, Fancd2-deficient embryos.
(E) Western analysis of proteins from both bcl2-GFP and GFP mRNA-injected Fancd2-deficient embryos, detected using an anti-GFP antibody.
Proteins extracted from ten embryos were loaded onto each lane. The -actin loading controls are shown (bottom).
(F) In this model, the RAD51-BRCA1-BRCA2-FANCD2-P53 complex localizes to S phase-specific chromosomal foci in the nucleus, participating
in ATP-dependent DNA repair by homologous recombination. Disruption of the complex by inactivation of any components may decrease
the efficiency of DNA repair and “translocates” P53 protein from repair foci to promoter sites, where it transcriptionally activates targets such
as P21WAF1/CIP1. However, loss of FANCD2 and RAD51, but not BRCA2, result in the p53-dependent activation of proapoptotic genes (see text).
Ub, monoubiquitination; mito, mitochondria.
75% cumulative risk of developing acute myeloid leuke- agents such as MMC and DEB (Wong and Buchwald,
2002). The failure to observe developmental defects inmia (AML), myelodysplastic syndrome (MDS), or solid
tumors by 40 years of age (Alter, 2003; Bogliolo et al., these mice may be explained by the incomplete loss of
the function of these proteins, or residual activity of2002). Vertebrate models of FA are needed to dissect
the mechanisms during embryogenesis that lead to the the Fancd2 protein (for example, intact ATM-dependent
phosphorylation of Fancd2 S222) in these knockoutdevelopmental defects observed in FA infants, as well
as the pathways responsible for the increased risk of mice, which acts downstream in the FA pathway (D’An-
drea and Grompe, 2003). Recently, two groups haveaplastic anemia and malignancy in older FA patients.
Interestingly, Fancd2 loss of function, through disrup- shown that Fancd2 and Fanca knockout mice develop
growth retardation and microophthalmia (Houghtaling ettion of the synthesis of the endogenous Fancd2 protein
during zebrafish embryogenesis, recapitulates many of al., 2003; Wong et al., 2003). These results are consistent
with our findings after the knockdown of zebrafishthe developmental defects observed in FA infants, such
as developmental retardation, shortened body length, Fancd2 levels using a morpholino.
Morpholino-based gene targeting is fully penetrantmicrocephaly, and microophthalmia. In previous stud-
ies, Fanca/, Fancc/, and Fancg/ knockout mice throughout the first 2 days of development, during which
the critical vertebrate processes of somitogenesis anddo not display these developmental defects, other than
impaired fertility. However, FA mouse embryonic fibro- organogenesis take place in the zebrafish embryo (Na-
sevicius and Ekker, 2000). With its rapid and externalblasts display increased sensitivity to crosslinking
Fancd2 and p53-Dependent Apoptosis
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embryonic development (most organs are formed at 30 Links between Fancd2 and p53-Dependent
Apoptotic Pathways during Developmenthpf) and optical clarity, the zebrafish is becoming a use-
The evidence of a link between p53-dependent apopto-ful model for the dissection of molecular pathways of
sis and the FA pathway has not been well established.human diseases, particularly those affecting early em-
Several groups have investigated the involvement ofbryonic development, such as FA. These unique advan-
p53-mediated apoptosis in vitro in FA cell lines aftertages enabled us to dynamically visualize the develop-
exposure to MMC, but the results are controversialment of Fancd2-deficient embryos and to identify the
(Kruyt et al., 1996; Ridet et al., 1997; Rosselli et al., 1995).exact embryonic stages between 12 and 14 hpf when
Our results establish a major role for p53-media-the onset of marked cellular apoptosis was observed.
ted apoptotic pathways in the developmental defectsA zebrafish model of Fanconi anemia will be useful
observed in Fancd2-deficient embryos. Injection of afor the discovery of modifier genes that affect this path-
p53-specific morpholino, which has been shown to ef-way, as well as the identification of small molecules
fectively knock down this protein and interrupt p53-that can affect FA phenotypes (Peterson et al., 2000). In
dependent molecular pathways (Langheinrich et al.,addition, a zebrafish line with stable Fancd2 inactivation
2002), completely abrogated the apoptotic phenotypewould be amenable to the analysis of adult FA pheno-
and rescued the developmental abnormalities observedtypes, such as the development of bone marrow failure,
in Fancd2-deficient embryos. Similar findings observedleukemia, and genome instability-related tumorigenesis.
after injection of the zebrafish bcl2 mRNA provided fur-
ther evidence that the developmental defects in Fancd2-
deficient embryos are due to inappropriate cellular apo-Fancd2 Is Essential to Prevent Inappropriate
ptosis. Interestingly, endogenous p53 mRNA levels wereApoptosis of Cells Undergoing Proliferative
elevated in Fancd2-deficient embryos, suggesting thatExpansion during Embryogenesis
the absence of a functional Fanconi pathway results inSeveral lines of evidence suggest that FANCD2 parti-
either transcriptional upregulation or an increase in thecipates with RAD51, BRCA1, and FANCD1/BRCA2 in
stability of p53 mRNA. Transcriptional upregulation ofthe homologous recombination (HR) repair of double-
p21WAF1/CIP1 and mdm2 observed in Fancd2-deficent em-stranded DNA breaks (DSB) under certain conditions
bryos is abrogated by the injection of the p53-specfic(Grompe and D’Andrea, 2001; Thompson and Schild,
morpholino, indicating that these p53 target genes are2002; Venkitaraman, 2002). For example, the FANCD2
affected in embryos deficient in Fancd2. Our results areprotein is monoubiquitinated, and colocalizes with the
consistent with those showing spontaneous upregula-RAD51 strand exchange protein, specifically during the
tion of p21WAF1/CIP1 in FA lymphoblasts (subtypes A andDNA synthesis phase (S) of the cell cycle (Taniguchi et
C; Waisfisz et al., 2002). Our results establish that p53al., 2002a). It is postulated that the FANCD2 protein in
is activated in the absence of a functional FA pathway,association with the core HR proteins plays a role in the
coincident with the normal proliferative expansion thatHR-dependent resolution of stalled replication forks. It
occurs in the CNS, eye, and other tissues during em-is estimated that more than 100 DSBs arise in each cell
bryogenesis.during the S phase transition (Thompson and Schild,
The genetic links between DNA repair proteins Rad51,2002). During early zebrafish embryogenesis, cells di-
Brca1, Brca2, and p53 have been established, and con-vide rapidly (every 30 min for the first 5.4 hr of develop-
tribute to the cellular proliferation defect in mice defi-ment) and lack discernable G1 or G2 phases of the cell
cient in these proteins (Hakem et al., 1996; Lim andcycle (Kane and Kimmel, 1993). It is anticipated that
Hasty, 1996; Ludwig et al., 1997; Patel et al., 1998; Tsu-considerable levels of spontaneously arising DNA dam-
zuki et al., 1996; Xu et al., 1999, 2001), but cellular apo-age accompany the proliferative expansion during early
ptosis is normal in mice embryos with the targeted dele-embryogenesis, thus greatly increasing the cellular de-
tion of either exons 10-11 of Brca2 (Brca210-11/10-11; Patel
pendence on the HR pathway to maintain developmental
et al., 1998; Suzuki et al., 1997) or exons 5-6 of Brca1
homeostasis and prevent mutations from accumulating
(Brca15-6/5-6) embryos (Hakem et al., 1996). Both of
in daughter cells. Maternal Fancd2 protein is continu- these deletions lead to premature stop codons in all
ously present during the critical embryonic stages of three reading frames and truncation of the encoded
gastrulation (9–12 hpf), even though fancd2 mRNA tran- proteins. In Brca111/11 (Xu et al., 2001) and Rad51 (Lim
scripts are undetectable. In addition, spontaneous ex- and Hasty, 1996) knockout embryos, increased apopto-
pression of the Fancd2-L form of the protein is observed sis was observed. Previous studies have shown that
in 18 and 28 hpf embryos. These results suggest that the p53 physically interacts with BRCA2 (Marmorstein et al.,
Fancd2 protein plays a pivotal role in the HR-dependent 1998) and BRCA1 (Ouchi et al., 1998). These results
repair of DNA damage produced during the burst of suggest a model in which disruption of the HR repair
cellular proliferation that accompanies embryologic de- complex by inactivation of any critical component re-
velopment. Abrogation of HR repair of DSBs in the ab- sults in the activation of p53-p21WAF1/CIP1-dependent pro-
sence of Fancd2 results in the activation of cellular death liferation arrest, but only the loss of Fancd2 and Rad51
machinery, increasing the level of cellular apoptosis (es- (or Brca1, under certain conditions) can cause p53-
pecially those tissues undergoing faster proliferative dependent activation of the cellular apoptotic machinery
expansion such as the CNS and eye), and thus contribut- (Figure 6F). Taken together, our work establishes a ge-
ing to the observed developmental defects. Our results netic link between FA and the p53-dependent apoptotic
support the hypothesis that birth defects in FA patients pathway, providing an explanation for the pathogenesis
may be the result of inappropriate apoptosis during em- of developmental defects in human FA patients.
With the recent observation that FA genes are highlybryogenesis (Cumming et al., 1996; Meyn, 1997).
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Total RNA was extracted from embryos at the indicated develop-expressed in CD34 hematopoietic stem cells (Aube et
mental stages using Trizol (GIBCO). Northern blotting was per-al., 2003), it will be intriguing to determine whether the
formed according to standard procedures.activation of p53-dependent apoptosis is implicated in
the pathogenesis of pancytopenia due to bone marrow
Whole-Mount mRNA In Situ Hybridization
failure that frequently develops in FA children during A 2.0 kb zebrafish fancd2 3	-RACE product was directionally sub-
the first decade of life. Similarly, it will be important to cloned into the pCS2 vector in the BamHI and XhoI sites. Antisense
mRNA was transcribed from BamHI-linearized plasmid using T3determine whether the inactivation of p53 itself or p53-
polymerase, and sense mRNA was transcribed from NotI-linearizedregulated proapoptotic genes occurs as part of the mo-
plasmid using SP6 polymerase as a control. Whole-mount in situlecular pathogenesis of acute myeloid leukemias and
hybridization was performed as described previously (Bennett etother tumors arising in FA adults.
al., 2001).
Experimental Procedures
Morpholinos
Two kinds of zebrafish fancd2 morpholinos with the same nucleotideFish Care
sequences were used for transfection into cultured cells and injec-Zebrafish maintenance, breeding, and staging were performed as
tion into embryos. The transfectable fancd2 morpholinos containeddescribed previously (Kimmel et al., 1995).
a prepaired duplex and partially complementary DNA oligonucleo-
tide, which made it easy to transfect cultured cells using ethoxylatedCloning and Mapping
polyethylenimine (EPEI; Morcos, 2001). The fancd2 morpholino (GeneThe zebrafish genome database (http://trace.ensembl.org/perl/
Tools; LLC) had the following sequence: fancd2mo, 5	-ATGACCGCTssahaview) was searched with the human FANCD2 protein sequence.
TCTTCTTACGCATCAT-3	, compared with the control morpholinoA genomic clone zfishC-a2495e11.q1c was identified that contained
(four-base pair mismatch), 5	-ATGAgCGCTaCTTCTaACGCtTCAT-two exons with one intervening intron. These two exons of the zebra-
3	. In some cases, fluorescein-tagged morpholinos were used tofish gene shared 41% amino acid identity with regions encoded by
monitor the transfection efficiency. The complementary sequenceexons 16 and 17 of human FANCD2, and the exon-intron boundaries
of the putative Fancd2 ATG start site is underlined and the fourwere completely conserved. 5	 and 3	 rapid amplification of cDNA
mismatched base pairs in the control morpholino are shown in lowerends (RACE) was used to amplify an adaptor-ligated SMART cDNA
case. The zebrafish p53 morpholino as well as four-base pair mis-library, prepared using zebrafish adult kidney mRNA (SMART RACE,
match control were used according to the published literature (Lang-Clontech). 5	-RACE primer 5	-TGGTGGTAGTCGTAGTCTCCGCTC
heinrich et al., 2002).GCC-3	 and 3	-RACE primer 5	-CCACCTACCACCACTCTCAACAC
CAC-3	 were used to amplify 1.8 kb and 3.6 kb fragments, respec-
Chromosome Breakage Analysistively. Sequence comparison was performed using the FASTA pro-
Approximately 80% confluent AB9 cells cultured in T25 flasks (25gram in the Genetics Computer Group (GCG) software.
cm2) were transfected with fancd2-specific morpholino as well asRadiation hybrid (RH) mapping was performed using the Goodfel-
the control, as described previously (Morcos, 2001). Briefly, 33.6 llow zebrafish T51 panel. Briefly, primer pairs were designed from
of 0.5 mM morpholino/DNA duplex stock was added to 1 ml ofthe 3	UTR of the fancd2 gene using OLIGO 6 software, forward
sterile ddH2O, followed by addition of 33.6 l of the EPEI specialprimer 5	-CGTAAGAAGAAGCGGTCAT-3	 and reverse primer 5	-
delivery solution. After incubation for 20 min at room temperature,ACTGCCAGGTGTCAGAGTGACTCC-3	. The fancd2 gene was posi-
10.8 ml of serum-free medium was added to this mixture and 3.5tioned relative to the frame markers mapped using the T51 panel by
ml aliquots were added to each T25 flask. After transfection, cellsusing the SAMapper 1.0 RH mapping program. Zebrafish homologs
were incubated for 3 hr, and then the medium was replaced withwere identified by the “reciprocal best hit” method as described
10 ml fresh serum-containing medium. Twenty-four hours later, thepreviously (Barbazuk et al., 2000; Liu et al., 2002). Sequence informa-
cells were treated with 0, 25, or 100 g/ml of diepoxybutane (DEB)tion and the map position of zebrafish genes can be found at http://
for 2 days, and then exposed to colcemid (10 g/ml) for 3 hr towww.genetics.wustl.edu/ and ZFIN (http://zfin.org/).
block exit from mitosis and harvested using 0.075 M KCl and 3:1
methanol:acetic acid. Slides were stained with Wright’s stain andImmunoblotting and Northern Analysis
50–100 metaphases were scored blindly for chromosomal breakageThe zebrafish AB9 fibroblast cells were cultured in DMEM supple-
and radial forms. Western analysis was performed in parallel tomented with 15% heat-inactivated fetal bovine serum (FBS) and
detect the block of protein synthesis.grown in a humidified 5% CO2-containing incubator at 28.5C. HeLa
cells were cultured as described previously (Garcia-Higuera et al.,
Morpholino and mRNA Microinjections2001). Cells were lysed with 1
 lysis buffer (50 mM Tris [pH 7.4],
The morpholinos were dissolved in 1
Danieu’s buffer (58 mM NaCl,150 mM NaCl, 1% Triton X-100, 0.02% sodium azide) supplemented
0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca[NO3]2, 5.0 mM HEPES [pHwith one tablet of protease inhibitor cocktail/10 ml (Roche). For
7.6]) to give a final stock concentration of 10 mg/ml. For injection,embryo protein extraction, embryos were rinsed twice in cold PBS
the morpholinos were diluted in 1
 Danieu’s buffer at concentra-solution, transferred into 1
 embryo lysis buffer (50 mM Tris [pH
tions from 1 to 4 mg/ml. One to two nanoliters was injected into the7.4], 10 mM EDTA, 100 mM NaCl, 0.1% SDS, 1 mM PMSF) supple-
one- to two-cell stage embryos. To ensure that the same dose wasmented with one tablet of protease inhibitor cocktail/10 ml, and then
injected, the same calibrated needle was first loaded to inject 2 nlhomogenized with a microfuge pestle and immediately centrifuged
of the fancd2 morpholino, rinsed with Danieu’s buffer, and thenat 12,000 rpm for 10 min. Protein concentrations were determined
used to inject 2 nl of the control morpholino.using the Bradford dye binding procedure (Bio-Rad).
The GFP-tagged zebrafish bcl2, human FANCD2, and GFP full-The protein extracts were diluted 1:2 with the Laemmli sample
length cDNA were subcloned into the pCS2 vector. The cappedbuffer (Bio-Rad), fractionated on SDS-polyacrylamide gels (7.5% for
mRNAs were transcribed from NotI-linearized plasmid using SP6FANCD2, 10% for green fluorescence protein, GFP-tagged Bcl2
RNA polymerase (Message Machine; Ambion), purified by phenol-protein), and transferred to nitrocellulose membranes. The blots
chloroform extraction, and dissolved in DEPC-treated water, andwere incubated with the primary antibody diluted in TBST (1:1,000
quantitated by spectrophotometer.dilution for both rabbit polyclonal anti-human FANCD2 antibody and
anti-GFP monoclonal antibody) for 1 hr and washed extensively.
After incubating with an anti-rabbit or -mouse IgG-horseradish per- Apoptosis Assay and Confocal Microscopy
Embryos grown to various developmental stages were fixed in 4%oxidase (HRP)-conjugated secondary antibody (diluted 1:5,000) at
room temperature for 1 hr, the blots were visualized by ECL kit paraformaldehyde overnight and dehydrated in ethanol:PBS series
(1:3, 1:1, 3:1), 5 min each at room temperature, followed by a 10(Santa Cruz) according to the manufacturer’s instructions. In addi-
tion, mouse monoclonal -actin antibody (AC-40; Sigma) at a dilution min incubation in acetone at20C and two 5–10 min rinses in PBS.
Embryos were further permeabilized by incubating them in a solutionof 1:500 was used to document equal loading per lane.
Fancd2 and p53-Dependent Apoptosis
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containing 0.1% Triton X-100 and 0.1% sodium citrate in PBS Suppression of apoptosis in hematopoietic factor-dependent pro-
genitor cell lines by expression of the FAC gene. Blood 88, 4558–(freshly prepared) for 15 min at room temperature followed by two
10 min rinses in PBS, and then were subjected to TUNEL assay 4567.
using the TMR-RED in situ cell death detection kit (Roche) according D’Andrea, A.D., and Grompe, M. (1997). Molecular biology of Fan-
to the manufacturer’s instructions. In some experiments, TUNEL- coni anemia: implications for diagnosis and therapy. Blood 90, 1725–
stained embryos were counterstained with Hoechst 33258 for 5 1736.
min, rinsed in PBS twice, flat mounted, and processed to confocal
D’Andrea, A.D., and Grompe, M. (2003). The Fanconi anaemia/BRCA
microscopic images. Optical sections were taken at 5 m intervals
pathway. Nat. Rev. Cancer 3, 23–34.
using Bio-Rad MRC 600 confocal microscopy. Four to five hundred
de Winter, J.P., Waisfisz, Q., Rooimans, M.A., van Berkel, C.G.,cells were counted.
Bosnoyan-Collins, L., Alon, N., Carreau, M., Bender, O., Demuth, I.,
Schindler, D., et al. (1998). The Fanconi anaemia group G gene
Single-Embryo RT-PCR FANCG is identical with XRCC9. Nat. Genet. 20, 281–283.
An individual embryo was rinsed twice with PBS and transferred
de Winter, J.P., Leveille, F., van Berkel, C.G., Rooimans, M.A., vaninto an RNase-free tube containing 100 l of Trizol (GIBCO) and 5
Der Weel, L., Steltenpool, J., Demuth, I., Morgan, N.V., Alon, N.,l of glycogen (Ambino). Total RNA was extracted according to the
Bosnoyan-Collins, L., et al. (2000a). Isolation of a cDNA representingmanufacturer’s manual and diluted in 10 l of DEPC-treated water.
the Fanconi anemia complementation group E gene. Am. J. Hum.One microliter of total RNA was used as a template and one-step
Genet. 67, 1306–1308.RT-PCR (Qiagen) was performed in a volume of 25 l. Primers were
de Winter, J.P., van der Weel, L., de Groot, J., Stone, S., Waisfisz,designed (Supplemental Data at http://www.developmentalcell.
Q., Arwert, F., Scheper, R.J., Kruyt, F.A., Hoatlin, M.E., and Joenje,com/cgi/content/full/5/6/903/DC1) using PRIMER 3 software. PCR
H. (2000b). The Fanconi anemia protein FANCF forms a nuclearconditions were as follows: 50C, 30 min; 95C, 15 min; 22 cycles
complex with FANCA, FANCC and FANCG. Hum. Mol. Genet. 9,of 94C, 30 s; 60C, 30 s; 72C, 1 min; then 72C, 10 min; 4C stored.
2665–2674.PCR products were separated on a 1.5% agarose gel.
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